Jones C
No ORCID on file
· 10 papers in corpus
· active 2013-2026
Study types
- review 1
Condition tags
- endometriosis 1
Top journals
Frequent coauthors
- Kevin Coward 4
- Banjoko A 2
- Soules M 2
- Burnell M 1
- Babbitt K 1
- Bahn S 1
- Cometti B 1
- Baker VL 1
- Celine Jones 1
- Benjamin E 1
2026
IntroductionPremenstrual symptoms are common physical, psychological, and behavioural symptoms that occur before the onset of menstruation. Despite their cyclical nature, these symptoms can be severe and burdensome, potentially interfering …
2026
review
2024
Rethinking the application of nanoparticles in women's reproductive health and assisted reproduction
Nanoparticles and nanotechnology may present opportunities to revolutionize the prevention, treatment and diagnosis of a range of reproductive health conditions in women. These technologies are also used to improve outcomes of assisted repr…
2023
In this pilot study, a human intravenous injection of low-dose endotoxin (lipopolysaccharide, LPS) model was used to test if fibromyalgia is associated with altered immune responses to Toll-like receptor 4 (TLR4) activation. Eight women wit…
2022
BackgroundOocyte activation deficiency (OAD) is attributed to the majority of cases underlying failure of ICSI cycles, the standard treatment for male factor infertility. Oocyte activation encompasses a series of concerted events, triggered…
2020
PurposeTo investigate the impact of a 3-month course of intracortical injections of autologous platelet-rich plasma (PRP) upon ovarian reserve markers versus no intervention in women with low ovarian reserve prior to undergoing assisted rep…
2018
Background: We report on a unique audit of seven sonographers self-reporting high visualization rates of normal postmenopausal ovaries in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). This audit was ordered …
2018
State-of-the-art applications of nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women's health. In this review, we provide a synopsis of potential ap…
2014
Study questionIs the ongoing pregnancy rate with a new aqueous formulation of subcutaneous progesterone (Prolutex(®)) non-inferior to vaginal progesterone (Endometrin(®)) when used for luteal phase support of in vitro fertilization?Summary …
2013
BackgroundFallopian tube secretory epithelial cells (FTSECs) have been implicated as a cell-of-origin for high-grade serous epithelial ovarian cancer. However, there are relatively few in vitro models of this tissue type available for use i…